Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Merkel Cell × Hematologic Tests × 90 days × Clear all

Sponsor

Conditions

Neoplasms 3 Smoking Cessation 2 Lung Neoplasms 2 Colorectal Neoplasms 2 Stomach Neoplasms 1 Pulmonary Disease, Chronic Obstructive 1 Prostatic Neoplasms 1 Neuroblastoma 1 Neoplasm, Residual 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Motor Activity 1 Inflammation 1 Esophageal Neoplasms 1 Dyspnea 1 Cardiovascular Diseases 1 Cardiotoxicity 1 Barrett Esophagus 1

Interventions

pembrolizumab 10 avelumab 8 Nivolumab 7 Specimen Handling 4 Ipilimumab 4 Biopsy 4 Magnetic Resonance Spectroscopy 3 cemiplimab 2 atezolizumab 2 aldesleukin 2 Radiosurgery 2 Immunoglobulin G 2 Cyclophosphamide 2 Bevacizumab 2 talimogene laherparepvec 1 sargramostim 1 relatlimab 1 regorafenib 1 prednylidene 1 lutetium Lu 177 dotatate 1 lenvatinib 1 fludarabine phosphate 1 fludarabine 1 durvalumab 1 deltacortene 1 decitabine and cedazuridine drug combination 1 aflibercept 1 X-Rays 1 Sirolimus 1 Saline Solution 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡